UK and US leaders meet to discuss global conflicts, despite policy differences straining their alliance.
Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making it a top performer in the S&P 500 and Nasdaq 100.
Federal probe investigates NY AG Letitia James over civil rights violations in high-profile cases against Trump and NRA.
UK and US leaders meet to discuss global conflicts, despite policy differences straining their alliance.
Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making it a top performer in the S&P 500 and Nasdaq 100.
Federal probe investigates NY AG Letitia James over civil rights violations in high-profile cases against Trump and NRA.